Skip to content
Company Analysis

Allurion Technologies, Inc. ALUR

A comprehensive view of key metrics, scores, and financial health for Allurion Technologies, Inc.

Overview of Allurion Technologies Inc.

ALUR NYQ
Healthcare Medical Devices Framework: Medical Devices & Diagnostics Micro Cap
Allurion Technologies Inc. (ALUR), is a Micro Cap company, in the Medical Devices industry, last closed at $0.02, about 0.0% overvalued vs fair value, -98.9% 1Y return, ranked 1092/1145 in sector.
Metrics Rev Growth -52.6% ROE 37.1% Gross Margin 62.8%
USD 0.02
110.00%
(Delayed)
• Vol 90d: 615.4%
52-Week Range
Market Cap
$12,657
Enterprise Value
$23.51M
Overall Score
View breakdown
Overall
Growth
Weak
Profitability
Weak
Health
Weak
Efficiency
Weak
Valuation
Weak
Growth
Weak
Profitability
Weak
Health
Weak
Efficiency
Weak
Valuation
Weak
Completeness: 88%
Confidence: 89%
Updated: Oct 24
Top Beats

Quick Facts

Website https://www.allurion.com
HQ Natick, MA
Employees 134
Fiscal year Dec 31

Next Events

No upcoming events available.

Fair Value Snapshot

Bear Base Bull
$-39
$-35
$-31
Current: $0.02

Engine Room Money Flow™

Micro Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$15.2M
-52.6%%
Gross Profit
$9.6M
-55.5%%
Operating Income (GAAP)
-$30.2M
39.9%%
EBITDA
-$27.7M
-760.5%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
62.8%
Good

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
1
Active Leaks
0/1
Improving
0
High Impact
1
Critical
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating Allurion Technologies, Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
39
/100
Developing
Scores based on quantitative metrics and qualitative factors
Full moat analysis

Key strengths

  • Superior Capital Returns Capital return quality is top-tier (score 0.95). High ROIC indicates the business is reinvesting at attractive rates.
  • Comfortable Interest Coverage Interest coverage quality is strong vs peers (score 0.66). Debt servicing capacity supports continued M&A optionality.

Key risks

  • Weak FCF Generation FCF margin quality lags peers (score 0.27). Below-peer FCF conversion is a MedTech quality warning.
  • Below-Peer Operating Margin Operating margin level is below peers (score 0.28). SG&A leverage needs improvement to close the gap.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Developing
46
Premium

Signals, strengths and risks for Pricing Power & Consumable Moat

Premium

Signals, strengths and risks for R&D Pipeline & Capital Returns

Premium

Signals, strengths and risks for FCF Quality & Cash Conversion

Premium

Signals, strengths and risks for Commercial Execution

Premium

Signals, strengths and risks for Capital Structure & Resilience

Premium

Signals, strengths and risks for Growth Durability

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Healthcare: MedTech (Devices & Supplies) vs Industry Peers 79% Coverage
Trade-Off Triangle Visualization A ternary plot showing ALUR's balance between Growth (18.2%), Profitability (50.1%), and Safety (31.7%). Growth 18% Safety 32% Profitability 50%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

16th percentile vs peers
17
Key Signals
TSR 3.8% 58p EPS Growth YoY -19.0% 23p Rev Growth YoY -52.6% 7p Revenue CAGR 3Y -38.1% 6p Asset Growth YoY -51.9% 2p
Strengths
  • ROIC in top 20% of peers (48.5%, 96th percentile)
Risks
  • Growth in bottom 20% of peers (percentile: 16)
  • Rev Growth YoY in bottom 20% of peers (-52.6%)

Profitability

45th percentile vs peers
46
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

28th percentile vs peers
29
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Allurion Technologies, Inc..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$-35.05
- - -
- upside
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000